focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 2.9 Announcement - Transaction in own shares

22 Nov 2022 07:00

RNS Number : 1318H
Allied Minds PLC
22 November 2022
 

22 November 2022

Allied Minds Plc

("the "Company")

 

Rule 2.9 Announcement - Transaction in own shares

 

Allied Minds plc (AIM: ALM, 'Allied Minds' or 'the Company') announces that, in accordance with the terms of its share buyback programme announced on 17 November 2022 ("Share Buyback Programme"), the Company purchased the following number of its Ordinary Shares of £0.01 each ("Ordinary Shares") through Numis Securities Limited. The Ordinary Shares purchased will be held in treasury until transferred by the Company to the directors and employees in satisfaction of awards under the 2014 Long Term Incentive Plan ("LTIP").

 

Date of purchase:

 21 November 2022

Volume of Allied Minds shares purchased:

326,414

Average market price paid per share (GBp):

9.4058

Highest price paid per share (GBp):

9.500

Lowest price paid per share (GBp):

9.400

 

In accordance with Rule 2.9 of The City Code on Takeovers and Mergers, Allied Minds confirms that, as at the date and time of this announcement, the remaining number of Ordinary Shares in issue will be 239,058,053 (excluding treasury shares), and the Company hold 592,220 Ordinary Shares in treasury. Therefore, the total voting rights in the Company will be 239,058,053. This figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

The International Securities Identification Number for Allied Minds Ordinary Shares is GB00BLRLH124.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the table below contains detailed information of the individual trades made by Numis Securities Limited as part of the Share Buyback Programme.

 

Schedule of Purchases - Individual Transactions

 

Number of ordinary shares purchased

Transaction price(GBp share)

Time of transaction (UK Time)

Transaction reference number

Trading venue

636

9.50

09:56:37

00062258935TRLO0

LSE

4666

9.50

10:02:10

00062259133TRLO0

LSE

13617

9.50

10:37:30

00062260253TRLO0

LSE

25000

9.40

11:01:11

00062260937TRLO0

LSE

41000

9.40

11:01:11

00062260938TRLO0

LSE

17959

9.40

11:01:18

00062260941TRLO0

LSE

7475

9.40

11:06:16

00062261101TRLO0

LSE

5465

9.40

11:06:16

00062261102TRLO0

LSE

8589

9.40

12:41:13

00062263806TRLO0

LSE

29914

9.40

12:41:13

00062263807TRLO0

LSE

29238

9.40

12:41:17

00062263809TRLO0

LSE

7027

9.40

12:41:17

00062263810TRLO0

LSE

26269

9.40

13:43:31

00062265917TRLO0

LSE

23145

9.40

14:36:38

00062267903TRLO0

LSE

14000

9.40

14:36:40

00062267905TRLO0

LSE

16737

9.40

14:37:06

00062267966TRLO0

LSE

15395

9.40

14:37:10

00062267973TRLO0

LSE

16236

9.40

14:37:13

00062267977TRLO0

LSE

14975

9.40

14:37:14

00062267978TRLO0

LSE

8592

9.40

16:29:30

00062273898TRLO0

LSE

479

9.40

16:29:30

00062273899TRLO0

LSE

 

The Company will make further regulatory announcements to shareholders in respect of purchases of Ordinary Shares by the Company as they occur.

 

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

Allied Minds plc

c/o Instinctif Partners

JTC (UK) Limited - Company Secretary

Christopher Gibbons

0203 846 9774

christopher.gibbons@jtcgroup.com

Instinctif Partners - Communications

Tim Linacre / Rozi Morris / Joe Quinlan

 

alliedminds@instinctif.com

 

The Company's LEI is 213800YB4G7YN21NLL72

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTTUAURRUOUAUUA
Date   Source Headline
9th Feb 20164:35 pmRNSPrice Monitoring Extension
9th Feb 20167:00 amRNSTrading Statement
4th Feb 20163:15 pmRNSHolding(s) in Company
4th Feb 20167:00 amRNSAllied Minds Subsidiary Produces Prototype
1st Feb 20167:00 amRNSAllied Minds Subsidiary Raises $22 million
15th Jan 20167:00 amRNSDirectorate Change
11th Jan 20165:31 pmRNSHolding(s) in Company
7th Jan 20164:57 pmRNSBlocklisting Six Monthly Return
3rd Nov 20153:55 pmRNSTotal Voting Rights
28th Oct 201510:53 amRNSHolding(s) in Company
13th Oct 20154:53 pmRNSHolding(s) in Company
12th Oct 20152:58 pmRNSHolding(s) in Company
5th Oct 20157:00 amRNSPrecision Biopsy Raises $33.6 Million
23rd Sep 20157:00 amRNSFederated Wireless NASCTN first pilot test
17th Sep 20157:00 amRNSFormation of HawkEye 360
4th Sep 20154:19 pmRNSDirectorate Change
1st Sep 20157:03 amRNSAllied Minds Names Joseph Pignato as CFO
27th Aug 20157:04 amRNSHalf Yearly Report
27th Aug 20157:01 amRNSABLS Licenses Technology and Molecules from Yale
25th Aug 20154:24 pmRNSAppointment of New Senior Independent Director
31st Jul 20153:02 pmRNSTotal Voting Rights
30th Jun 20159:37 amRNSTotal Voting Rights
26th Jun 20155:16 pmRNSDirector/PDMR Shareholding
22nd Jun 20157:00 amRNSABLS licenses IP from Harvard
10th Jun 20155:06 pmRNSBlocklisting Six Monthly Return
5th Jun 20157:30 amRNSLong Term Incentive Plan
5th Jun 20157:00 amRNSAppointment of Kevin Sharer to Board of Directors
28th May 20156:06 pmRNSResult of AGM
28th May 20157:00 amRNSAGM Statement
22nd May 20154:07 pmRNSHolding(s) in Company
21st May 20152:17 pmRNSHolding(s) in Company
20th May 20157:33 amRNSResults of Placing
28th Apr 201512:00 pmRNSCapital Markets Day
28th Apr 20157:31 amRNSAnnual Results Release
28th Apr 20157:00 amRNSAppointment of New Non-Executive Chairman
22nd Apr 20157:00 amRNSSciFluor Life Sciences Raises $30 Million
2nd Apr 20153:40 pmRNSHolding(s) in Company
1st Apr 20154:33 pmRNSTotal Voting Rights
26th Mar 20152:30 pmRNSNotice of Results and Capital Markets Day
20th Mar 20154:35 pmRNSPrice Monitoring Extension
10th Mar 20157:02 amRNSAllied Minds Announces the Formation of BridgeSat
3rd Feb 20154:06 pmRNSHolding(s) in Company
8th Jan 20157:00 amRNSSciFluor Life Sciences Awarded U.S. Patent
4th Dec 20147:00 amRNSSciFluor Life Sciences Awarded U.S. Patent
19th Nov 201410:03 amRNSBlock Listing of Shares
12th Nov 20147:00 amRNSAllied Minds Appointment of Joint Broker
5th Nov 20147:00 amRNSAllied Minds Appoints Donna See as Vice President
30th Oct 20147:00 amRNSAllied Minds forms Seamless Devices, Inc.
20th Oct 20143:12 pmRNSHolding(s) in Company
9th Oct 201410:11 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.